Position in AZN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$6,232,430
-$214,889 QoQ
Shares Held
32,868
+0.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#362
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AZZAD ASSET MANAGEMENT INC /ADV holds $52,280,324 across 9 Drug Manufacturers - General names. AZN ranks #4 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
87,982 | $11,305,687 | |
| 2 | ABBV |
AbbVie Inc.
|
31,610 | $7,954,340 | |
| 3 | LLY |
ELI LILLY & Co
|
5,597 | $6,713,210 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
32,868 | $6,232,430 | |
| 5 | JNJ |
Johnson & Johnson
|
24,292 | $6,169,439 | |
| 6 | NVO |
Novo Nordisk A S
|
107,307 | $5,144,297 | |
| 7 | NVS |
Novartis AG
|
30,427 | $4,768,519 | |
| 8 | AMGN |
Amgen Inc
|
9,364 | $3,390,891 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,232,430 | 32,868 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $6,447,319 | 32,691 | Shares | Sole | 2026-04-30 | |
| No filing history on record for this holder in this stock. | ||||||